ANAB AnaptysBio, Inc.
$53.87▼ -2.34%
Healthcare
Other
After hours
$53.87▲ +0.00%
Sep 11, 7:30 PM ET
Volume 336.2K
Avg Volume (10D) 547.7K
Key Metrics & Fundamentals
Market Cap
$1.60B
P/E Ratio
–
Div Yield
–%
52W Range
11.40 - 72.36
% vs 50 MA
-6.09%
% vs 200 MA
14.51%
RSI-14
40.5
MACD Histogram
-0.3100
Beta (1Y vs SPY)
1.03
Free Cash Flow
-$25.94M
Gross Rev
$25.56M
Gross Profit
$25.56M
EBITDA
-$31.38M
COGS
–
Operating Exp
$60.19M
Operating Income
-$34.64M
EBIT
-$34.64M
Pretax Income
-$52.84M
Net Income
-$52.88M
EPS (Diluted)
-1.84
Price & Volume History
Loading chart…
Recent News
Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB)
Insider Monkey · Sep 9, 2026 2:34 PM
Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 1, 2026 8:15 PM
GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control
Insider Monkey · Aug 17, 2026 3:03 PM
CorMedix (CRMD) Q2 Earnings and Revenues Top Estimates
Zacks · Aug 13, 2026 12:45 PM
What Makes AnaptysBio (ANAB) an Investment Bet?
Insider Monkey · Jul 14, 2026 2:56 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See ANAB's money flow as a full page
Social Sentiment
Avg +0.80 · 2 posts
DDNewsPriceTargetAnaptysBio ($ANAB) - biotech with key upcoming price catalysts
r/investing · Jul 14, 2026
The post highlights potential catalysts and a positive royalty structure for ANAB.
positive
+0.80
DDNewsDiscussionAnaptysBio ($ANAB)
r/wallstreetbets · Jul 14, 2026
Discusses positive aspects of the company's royalty model and blockbuster drug Jemperli.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.